-
2
-
-
0031059723
-
Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin
-
Donnenfeld E.D., Perry H.D., Snyder R.W., et al. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin. Arch Ophthalmol. 115:1997;173-176
-
(1997)
Arch Ophthalmol
, vol.115
, pp. 173-176
-
-
Donnenfeld, E.D.1
Perry, H.D.2
Snyder, R.W.3
-
3
-
-
0033513004
-
Aqueous and vitreous penetration of levofloxacin after oral administration
-
Fiscella R.G., Nguyen T.K., Cwik M.J., et al. Aqueous and vitreous penetration of levofloxacin after oral administration. Ophthalmology. 106:1999;2286-2290
-
(1999)
Ophthalmology
, vol.106
, pp. 2286-2290
-
-
Fiscella, R.G.1
Nguyen, T.K.2
Cwik, M.J.3
-
4
-
-
0031467994
-
Ofloxacin penetration into the eye after intravenous and topical administration
-
Fiscella R.G., Shapiro M.J., Solomon M.J., et al. Ofloxacin penetration into the eye after intravenous and topical administration. Retina. 17:1997;535-539
-
(1997)
Retina
, vol.17
, pp. 535-539
-
-
Fiscella, R.G.1
Shapiro, M.J.2
Solomon, M.J.3
-
5
-
-
0032471272
-
Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration
-
Cekic O., Batman C., Yasar U., et al. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration. Retina. 18:1998;521-525
-
(1998)
Retina
, vol.18
, pp. 521-525
-
-
Cekic, O.1
Batman, C.2
Yasar, U.3
-
6
-
-
0027738008
-
Intravenous cefazolin in penetrating eye injuries. Treatment of experimental posttraumatic endophthalmitis
-
Alfaro D.V., Runyan T., Kirkman E., et al. Intravenous cefazolin in penetrating eye injuries. Treatment of experimental posttraumatic endophthalmitis. Retina. 13:1993;331-334
-
(1993)
Retina
, vol.13
, pp. 331-334
-
-
Alfaro, D.V.1
Runyan, T.2
Kirkman, E.3
-
7
-
-
0037336393
-
Vitreous and aqueous penetration of orally administered gatifloxacin in humans
-
Hariprasad S.M., Mieler W.F., Holz E.R. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol. 121:2003;345-350
-
(2003)
Arch Ophthalmol
, vol.121
, pp. 345-350
-
-
Hariprasad, S.M.1
Mieler, W.F.2
Holz, E.R.3
-
8
-
-
0032471459
-
Intraocular penetration of gentamicin after once-daily aminoglycoside dosing
-
Fiscella R.G., Gieser J., Phillpotts B., et al. Intraocular penetration of gentamicin after once-daily aminoglycoside dosing. Retina. 18:1998;339-342
-
(1998)
Retina
, vol.18
, pp. 339-342
-
-
Fiscella, R.G.1
Gieser, J.2
Phillpotts, B.3
-
9
-
-
0029079343
-
Vancomycin levels in the vitreous cavity after intravenous administration
-
Meredith T.A., Aguilar H.E., Shaarawy A., et al. Vancomycin levels in the vitreous cavity after intravenous administration. Am J Ophthalmol. 119:1995;774-778
-
(1995)
Am J Ophthalmol
, vol.119
, pp. 774-778
-
-
Meredith, T.A.1
Aguilar, H.E.2
Shaarawy, A.3
-
10
-
-
0035063748
-
Linezolid: A review of its use in the management of serious Gram-positive infections
-
Perry C.M., Jarvis B. Linezolid a review of its use in the management of serious Gram-positive infections. Drugs. 61:2001;525-551
-
(2001)
Drugs
, vol.61
, pp. 525-551
-
-
Perry, C.M.1
Jarvis, B.2
-
11
-
-
0035830306
-
Oxazolidinone antibiotics
-
Diekema D.J., Jones R.N. Oxazolidinone antibiotics. Lancet. 358:2001;1975-1982
-
(2001)
Lancet
, vol.358
, pp. 1975-1982
-
-
Diekema, D.J.1
Jones, R.N.2
-
12
-
-
0036604489
-
Linezolid versus vancomycin for the treatment of methicilin-resistant Staphylococcus aureus infections
-
Stevens D.L., Herr D., Lampiris H., et al. Linezolid versus vancomycin for the treatment of methicilin-resistant Staphylococcus aureus infections. Clin Infect Dis. 34:2002;1481-1490
-
(2002)
Clin Infect Dis
, vol.34
, pp. 1481-1490
-
-
Stevens, D.L.1
Herr, D.2
Lampiris, H.3
-
13
-
-
0037115316
-
Linezolid: An oxazolidinone antimicrobial agent
-
Paladino J.A. Linezolid an oxazolidinone antimicrobial agent. Am J Health Syst Pharm. 59:2002;2413-2425
-
(2002)
Am J Health Syst Pharm
, vol.59
, pp. 2413-2425
-
-
Paladino, J.A.1
-
14
-
-
0035660591
-
Linezolid absolute bioavailability and the effect of food on oral bioavailability
-
Welshman I.R., Sisson T.A., Jungbluth G.L., et al. Linezolid absolute bioavailability and the effect of food on oral bioavailability. Biopharm Drug Dispos. 22:2001;91-97
-
(2001)
Biopharm Drug Dispos
, vol.22
, pp. 91-97
-
-
Welshman, I.R.1
Sisson, T.A.2
Jungbluth, G.L.3
-
15
-
-
0037311453
-
Population pharmacokinetics of linezolid in patients treated in a compassionate-use program
-
Meagher A.K., Forrest A., Rayner C.R., et al. Population pharmacokinetics of linezolid in patients treated in a compassionate-use program. Antimicrob Agents Chemother. 47:2003;548-553
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 548-553
-
-
Meagher, A.K.1
Forrest, A.2
Rayner, C.R.3
-
16
-
-
0002157211
-
Ocular pharmacokinetics/pharmacodynamics
-
A.K. Mitra. New York: Marcel Dekker, Inc
-
Schoenwald R.D. Ocular pharmacokinetics/pharmacodynamics. Mitra A.K. Ophthalmic Drug Delivery Systems. 1993;83-110 Marcel Dekker, Inc, New York
-
(1993)
Ophthalmic Drug Delivery Systems
, pp. 83-110
-
-
Schoenwald, R.D.1
-
17
-
-
0032948063
-
Posttraumatic endophthalmitis
-
Meredith T.A. Posttraumatic endophthalmitis. Arch Ophthalmol. 117:1999;520-521
-
(1999)
Arch Ophthalmol
, vol.117
, pp. 520-521
-
-
Meredith, T.A.1
-
18
-
-
0028832334
-
Endophthalmitis following penetrating trauma: Risk factors and visual acuity outcomes
-
Thompson W.S., Rubsamen P.E., Flynn H.W. Jr, et al. Endophthalmitis following penetrating trauma risk factors and visual acuity outcomes. Ophthalmology. 102:1995;1696-1701
-
(1995)
Ophthalmology
, vol.102
, pp. 1696-1701
-
-
Thompson, W.S.1
Rubsamen, P.E.2
Flynn Jr., H.W.3
-
20
-
-
0035205670
-
Human aqueous humor levels of oral ciprofloxacin, levofloxacin and moxifloxacin
-
Garcia-Saenz M.C., Arias-Puente A., Fresnadillo-Martinez M.J., Carrasco-Font C. Human aqueous humor levels of oral ciprofloxacin, levofloxacin and moxifloxacin. J Cataract Refract Surg. 27:2001;1969-1974
-
(2001)
J Cataract Refract Surg
, vol.27
, pp. 1969-1974
-
-
Garcia-Saenz, M.C.1
Arias-Puente, A.2
Fresnadillo-Martinez, M.J.3
Carrasco-Font, C.4
|